Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
Jie Mei, Ziyi Fu, Yun Cai, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106027-106027
Open Access | Times Cited: 13

Showing 13 citing articles:

Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma
Lianmin Zhang, Yanan Cui, Guangyao Zhou, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010008-e010008
Open Access | Times Cited: 23
CD47 is a tumor cell-derived exosomal signature and regulates tumor immune microenvironment and immunotherapy responses
Yifei Luan, Yinghui Zhang, Shangjin Li, et al.
Translational Oncology (2025) Vol. 53, pp. 102291-102291
Open Access | Times Cited: 1
Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
Rui Xu, Mengyun Wan, Jiadong Pan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
Pengzhou Kong, Jiao Ye, Meng Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
Jie Mei, Yun Cai, Rui Xu, et al.
STAR Protocols (2023) Vol. 4, Iss. 2, pp. 102258-102258
Open Access | Times Cited: 10
GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer
Yunfei Wang, Pan Jiadong, Fangmei An, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
Honghong Fan, Yuxin Shi, Huiyu Wang, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1757-1769
Open Access | Times Cited: 4
Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer
Yixuan Wu, Zhou Zhou, Qianyi Qi, et al.
Aging (2024)
Open Access | Times Cited: 1
Cost-Effective Whole Transcriptome Sequencing Landscape and Diagnostic Potential Biomarkers in Active Tuberculosis
Zaiqiao Sun, Boxiao He, Zhifeng Yang, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 2318-2332
Closed Access
Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma
Guohai Xiong, Jin-Mei Shan, Qingguo Chong, et al.
Aging (2024)
Open Access
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma
Zehua He, Hong Yang, Qingfeng Chen, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 890-907
Open Access
PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Wei Huang, Zhengtao Qian, Yuxin Shi, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 747-758
Open Access | Times Cited: 1
Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
Yuxin Shi, Qinglin Zhang, Jie Mei, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access
Page 1

Scroll to top